Effects of GRA in Patients With Type 1

NCT04779645 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: REMD-477
DRUG: Placebo

Sponsor

University of California, San Diego

Collaborators

[object Object]